Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932471-24-000783
Filing Date
2024-11-04
Accepted
2024-11-04 14:15:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 UnitedStates_13G__X4Pharmace.txt SC 13G/A 4050
  Complete submission text file 0000932471-24-000783.txt   5724
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90199 | Film No.: 241422620
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)